Skip to main content
An official website of the United States government

Chemopreventive Agent Development

Designs, develops, implements, and monitors research on interventions that may block, reverse, or delay the early stages of cancer. Investigates nutrients, micronutrients, natural products, pharmacologic agents, biomolecules, and vaccines from preclinical to early-phase I clinical studies. Helps investigators to bridge the gaps between biology and identifying potential targets, and between discovery of targets and agents and clinical testing in people.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

Major Programs

Staff List

Photo Name, Email, Phone Room Group(s)/Office
Asefa, Wosene
wosene.asefa@nih.gov
240-276-6422
5E504 Program Support Assistant | Chemopreventive Agent Development
Biswas, Kajal, Ph.D.
kajal.biswas2@nih.gov
240-276-5614
5E540 Program Officer | Chemopreventive Agent Development
Cholewa, Brian, Ph.D.
brian.cholewa@nih.gov
240-276-7545
5E446 Deputy Chief | Chemopreventive Agent Development
Clifford, John, Ph.D.
john.clifford@nih.gov
202-235-4482
5E430 Program Officer | Chemopreventive Agent Development
Gunasekharan, Vignesh, Ph.D.
vignesh.gunasekharan@nih.gov
240-276-5814
5E438 Program Officer | Chemopreventive Agent Development
Mohammed, Altaf, Ph.D.
altaf.mohammed@nih.gov
240-276-6082
5E542 Deputy Chief | Chemopreventive Agent Development
Nalli, Ancy, Ph.D., M.S.
ancy.nalli@nih.gov
202-276-5265
5E536 Program Officer | Chemopreventive Agent Development
Sei, Shizuko, M.D.
shizuko.sei@nih.gov
240-276-5005
5E452 Co-Chief | Chemopreventive Agent Development
Shoemaker, Robert, Ph.D.
robert.shoemaker@nih.gov
240-276-7077
5E454 Co-Chief | Chemopreventive Agent Development
Acting Chief | Nutritional Science
Vlad, Anda, M.D., Ph.D.
anda.vlad@nih.gov
240-276-6422
5E538 Program Officer | Chemopreventive Agent Development

Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Cantuaria, Guilherme

Northside Hospital Atlanta
United States

Georgia NCI Community Oncology Research Program (GA NCORP) 3UG1CA189997-11S1 Vanessa A. White, M.P.H.
Cao, Weidan

Ohio State University
United States

Treatment-Related Cardiotoxicity Risk Prediction for Breast Cancer Patients with a Multimodal AI-based System 1R01CA301579-01 Eileen Dimond, R.N., M.S.
Cao, Yin

Washington University
United States

PROSPECT-Global Consortium and Risk Factor Discovery 3OT2CA297576-01S1 Asad Umar, D.V.M., Ph.D.
Cao, Shugeng

University Of Hawaii At Hilo
United States

Discovery of novel natural TEAD inhibitors for the chemoprevention of liver tumors 5UG3CA290375-02 Altaf Mohammed, Ph.D.
Cao, Yin

Washington University
United States

Obesity, sedentary behaviors, and diet quality for prevention and early detection of early-onset colorectal neoplasia 4R37CA246175-06 Asad Umar, D.V.M., Ph.D.
Carlson, Jay W

Ozark Health Ventures, Llc
United States

Ozark Health Ventures LLC dba Cancer Research for the Ozarks (CRO) 3UG1CA189822-11S1 Vanessa A. White, M.P.H.
Carson, Tiffany Lashaun

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Determining the structural- and functional-level effects of diet-specific interventions on the gut microbiota of a diverse sample of Southern United States adults 5R01CA253219-06 Young Kim, Ph.D.
Castilla, Lucio H.

Univ Of Massachusetts Med Sch Worcester
United States

Study of tyrosine kinase inhibitors as preventive therapy in RUNX1-FPD 1U01CA296350-01 Marjorie Perloff, M.D.
Castro, Cesar M

Massachusetts General Hospital
United States

Composing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approach 3U01CA279858-03S2 Christos Patriotis, Ph.D., M.Sc.
Caulin, Carlos

University Of Arizona
United States

Genetic Alterations That Confer High Risk to Oral Premalignant Lesions 5R01CA274857-04
Caywood, Emi H

Nemours Children'S Hospital, Delaware
United States

Nemours NCI Community Oncology Research Program (NCORP) 3UG1CA189958-11S1 Vanessa A. White, M.P.H.
Chak, Amitabh

Case Western Reserve University
United States

Pathways of Injury and Repair in Barrett's Carcinogenesis 5P01CA269019-03 Asad Umar, D.V.M., Ph.D.
Chan, Alexandre

University Of California-Irvine
United States

Neurotrophic strategy to mitigate chemotherapy-related brain injury 5R01CA276212-03 John Clifford, Ph.D.
Chan, Andrew T

Massachusetts General Hospital
United States

MGH- PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors 3OT2CA297680-01S1 Asad Umar, D.V.M., Ph.D.
Chan, Daniel Wanyui

Johns Hopkins University
United States

Development of a panel of multiplex biomarkers for the early detection of pancreatic ductal adenocarcinoma and high-risk lesions 5U01CA274514-03 Matthew Young, Ph.D.